Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis
Antoine Klauser(University of Geneva), Jeroen J.G. Geurts(Amsterdam Neuroscience), Petra J. W. Pouwels(Amsterdam UMC Location University of Amsterdam), Frederik Barkhof(Netherlands Institute for Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam), Oliver T. Wiebenga(Universidade Federal do Rio de Janeiro), A. J. C. Eijlers(Amsterdam Neuroscience)
Cited by 27
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k